Business
Viveve(R) Announces First Quarter Financial Highlights
Viveve(R) Announces First Quarter Financial Highlights.
About this update from Viveve Medical, Inc.
[{"type":"text","content":"\nViveve(R) Announces First Quarter Financial Highlights \n\nViveve(R) Announces First Quarter Financial Highlights\n\n\nCompany Achieves Record Quarter Sales and Significantly Increases Installed Base of Viveve Systems for Non-Surgical Treatment of Vaginal Laxity \n\n\n SUNNYVALE, CA--(Marketwired - April 19, 2016) - Viveve Medical, Inc. (\"Viveve\") (OTCQB: VIVMD), a medical technology company focused on women's health, today announced top-line financial results for the quarterly period ended March 31, 2016.\n Financial Result Highlights\n For the quarterly period ended March 31, 2016, total revenue from the sale of 33 Viveve Systems and 474 disposable treatment tips is expected to be approximately $1.3 million -- a 73% increase over total revenue for the quarterly period ended December 31, 2015.\"We now have a total commercial installed base of 75 Viveve Systems around the world. We anticipate further increases in our installed base throughout 2016 as we continue to achieve regulatory clearances in additional countries,\" said Scott Durbin, chief financial officer of Viveve.\"We believe this quarter's financial highlights demonstrate the demand we are seeing for a safe, non-invasive and clinically proven treatment for vaginal laxity. In addition, we anticipate that the results from our Viveve I clinical study, which we look forward to sharing in the near future, will further validate the clinical safety and efficacy of our technology and its use in treating a condition that affects millions of women worldwide,\" said Patricia Scheller, chief executive officer of Viveve. Viveve cautions that its anticipated revenue results are preliminary based on the most current information available and are subject to completion of the consolidated financial statements for the first quarter of 2016. The company anticipates reporting its first quarter financial results in May 2016. \n About Viveve\n Viveve Medical, Inc., is a women's health company passionately committed to advancing new solutions to improve women's overall well-being and quality of life. The company's lead product, the globally patented Viveve System, is a non-surgical, non-ablative medical device that remodels collagen and restores tissue with only one treatment session. The Viveve System treats the condition of vaginal laxity that can result in decreas...